This inventor holds 4 USPTO granted patents and 1 published patent application, plus 2 CIPO patents. Top assignee: Topotarget UK Limited. Active years: 2005-2011.
Company Filing History:
Years Active: 2005-2011
Title: Kathryn G Moore: Innovator in HDAC Inhibitors
Introduction
Kathryn G Moore is a prominent inventor based in Abingdon, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit histone deacetylases (HDAC). With a total of 4 patents to her name, her work is paving the way for new therapeutic options in treating various proliferative conditions.
Latest Patents
One of her latest patents focuses on carbamic acid compounds comprising an amide linkage as HDAC inhibitors. This invention pertains to certain active carbamic acid compounds that inhibit HDAC activity. The compounds have a specific formula where A is an aryl group, Q is an aryl leader group with a backbone of at least two carbon atoms, and J is an amide linkage. The invention also includes pharmaceutical compositions comprising these compounds and their use in vitro and in vivo to inhibit HDAC, particularly in conditions such as cancer and psoriasis.
Career Highlights
Kathryn G Moore is associated with Topotarget UK Limited, where she continues to innovate in the field of drug development. Her work is characterized by a strong focus on creating effective treatments for serious health conditions.
Collaborations
Some of her notable coworkers include Clare J Watkins and Maria Rosario Romero-Martin, who contribute to her research efforts and collaborative projects.
Conclusion
Kathryn G Moore's contributions to the field of HDAC inhibitors highlight her role as a leading inventor in pharmaceutical innovation. Her work not only advances scientific understanding but also holds promise for future medical applications.